oncology SA
Oncology
Lymph node sampling | · Indications: if enlarged, suspect underlying infectious disease (e.g. FIP, fungi, leishmania), staging of malignant disease (can see metastatic spread) · Precautions when sampling: o Non-suction technique to minimise blood contamination o Spread gently on slide as fragile cells o If enlarged, don’t sample centre as likely necrotic o Take sample BEFORE giving steroids · Normal LN – 90% small lymphocytes, 5-10% small + medium lymphocytes o + plasma cells, macrophages, mast cells, neutrophils (rare) |
Lymph node pathology | · Reactive hyperplasia – increased large lymphocytes, increased plasma cells (vacuole) · Lymphadenitis o Neutrophilic – lots of neutrophils (causes: bacterial, immune-mediated, neoplastic) o Eosinophilic – lots of eosinophils (causes: hypersensitivity reaction, parasites, idiopathic, paraneoplastic) o Granulomatous/pyogranulomatous – incr. macrophages +/- neutrophils (causes: chronic inflammatory conditions, e,g. fungal infections, FIP, leishmaniasis) · Lymphoma – lots of large immature lymphocytes (bigger than RBCs), more mitosis, macrophages · Metastatic neoplasia – cells present that shouldn’t be (e.g. mast cells) |
Thymoma vs lymphoma | · Thymoma – originates from epithelial cells, see epithelial cells, small lymphocytes, occasional mast cell o Diagnosis: imaging (see mass in cranial mediastinum), cytology, histopathology o Treatment: surgery · Lymphoma – originates from lymphocytes, see lots of large lymphocytes o Diagnosis: imaging (see mass in cranial mediastinum), cytology, histopathology o Treatment: chemotherapy (surgery not suitable as entire lymphatic system affected) |
Myeloid neoplasia’s | · Myeloid leukaemia – acute or chronic · Mast cell tumour o Granulocytes that undergo malignant transformation, locally invasive, risk of degranulation o Treatment: masitib, toceranib, tigilanol tigilate · Histiocytoma o Usually benign, seen in dogs <2yr, regress independently · Transmissible venereal tumour o Infected tumour, transmitted during mating o Treatment: chemotherapy (vincristine) |
Lymphoid neoplasia’s | · Lymphoid leukaemia – acute or chronic · Plasmacytoma o Benign cutaneous mass, can be locally invasive, found on skin, oral cavity, rectal mucosa · Lymphoma o Develops from malignant transformation of lymphocytes – can occur anywhere o Multicentric lymphoma – affects multiple lymph nodes |
Splenic mass | · Most common: haemangiosarcoma (dogs), splenic MCT (cats) · Presentation: abdominal distension, pain on abdo palp, anaemia, lethargy, cough (due to metastatic spread), acute emergency/collapse (if torsion and blood supply cut off) · Prognosis: splenectomy = 3m, splenectomy + chemo = 6m |
Paraneoplastic syndromes | · Hypercalcaemia · Hyperviscosity – blood becomes thick ® harder to move through vessels ® high BP · Hormones – some tumours release oestrogen ® bilateral symmetrical alopecia in ovarian tumours, hyperoestrogenism in Sertoli cell tumours · MCT – mast cells release histamine, degranulation ® itching + also V+/D+ |
Staging a tumour | · Haematology and biochemistry – check for bone marrow involvement, liver parameters · Ultrasound – to screen liver and spleen · Thoracic radiography – check if mets to the liver To stage a tumour: · Tumour – grade, size, ulceration, how fixed · Lymph node – metastasis to local LN? · Distant metastasis – other LNs in body, other organs, e.g. liver, spleen, lungs |
Management of tumours | · Surgical excision o Radical – e.g. amputation o Curative intent – 3cm lateral margins, 1 fascial plane o Marginal surgery – leave microscopic remnants behind o Cytoreductive therapy – leave macroscopic remnants behind · Steroids – reduce inflammation, provide analgesia o But limited effects, unless use alongside chemotherapy · Chemotherapy: o Medical therapy o Cytotoxic drugs o Anti-neoplastic agents o Immunosuppressive drugs o Considerations: appropriate restrain, extravasation (make sure in vein), side effects (reduced immunity, whisker/fur loss, V+/D+) |